Baseline clinical factors that predict treatment response varied by the type of therapy utilized among patients with plaque psoriasis.

Oral probiotic supplementation may be beneficial for skin hydration and barrier function, but additional research is needed.

Results of a systematic review and meta-analysis confirm the efficacy and safety of oral JAK inhibitors for the treatment of alopecia areata.

The FDA has accepted a New Drug Application with Priority Review for zasocitinib, an investigational oral TYK2 inhibitor for plaque psoriasis.

A coroner has confirmed that measles killed 1 infant last month, but federal officials still are not counting the death in their tally.

Women were generally excluded from clinical trials until the 1990s; in 1993, the NIH inclusion policy was codified into ...

Low-dose micronized isotretinoin was an effective and safe therapy option for severe recalcitrant nodular acne in real-world settings.

Adults who adhere to healthy habits regarding alcohol consumption, smoking cessation, sleep, and physical activity have a lower risk for incident AD.

Upadacitinib may be a safe and effective future therapy option for the management of severe alopecia areata in adults and adolescents.

Longitudinal histopathologic patterns of melanocytic lesions may be used to improve risk stratification for melanoma and other adverse outcomes.

A frozen berry blend sold at Walmart in 16 states has been pulled from shelves, widening a recall connected to an ongoing E coli outbreak.

The FDA grants Fast Track designation to inhaled treprostinil (Yutrepia) for systemic sclerosis-associated Raynaud phenomenon, ahead of the phase 2a RE-WARM trial.